Clinical Trials

42 enrolled

Breast Neoplasms, Recurrence, Triple Negative Breast Neoplasms

NCT06949410 2026-04-22

HER2 Vaccine for Locally Advanced Breast Cancer

36 enrolled

Breast Neoplasms

NCT07069595 2026-04-22

PREDICT-RD

78 enrolled

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT07123649 2026-04-22

I-MAMMO

364 enrolled

Breast Neoplasms

NCT07198581 2026-04-22

ALLIANCE

174 enrolled

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT07238088 2026-04-22

MAMO

1,020 enrolled

Breast Neoplasms

NCT07546331 2026-04-22

Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction

40 enrolled

Breast Neoplasms

NCT04003038 2026-04-21

Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery

80 enrolled

BreastOther

Breast Neoplasms, Obesity

NCT06430541 2026-04-21

Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence

20 enrolled

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

NCT06608446 2026-04-21

LINFO

155 enrolled

Breast Neoplasms

NCT07218432 2026-04-21

A Study of the TheraBionic P1 Device in Breast Cancer

24 enrolled

Breast Neoplasms

NCT07378306 2026-04-21

FACT-TN

80 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07542106 2026-04-21

Effectiveness of a Visual Biofeedback Program Versus Conventional Physiotherapy on Shoulder Mobility, Strength, and Function in Women After Breast Cancer Surgery

40 enrolled

Breast Neoplasms

NCT07542496 2026-04-21

PERTUREAL

1,000 enrolled

Breast Neoplasms, Neoplasms

NCT04740697 2026-04-20

EUTACAM

200 enrolled

Treatment Adherence and Compliance, Breast Neoplasms

NCT05491226 2026-04-20

Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation

35 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06134375 2026-04-20

A Study of Tetrathiomolybdate (TM) Plus Capecitabine

Phase 1/2 Recruiting

204 enrolled

Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT06374459 2026-04-20

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

Phase 1/2 Recruiting

152 enrolled

Breast Neoplasms

NCT07525869 2026-04-20

An Open-label Prospective Study to Evaluate the Efficacy and Safety of Pegfilgrastim in Triple-Negative Breast Cancer Patients Receiving AC Regimen Following Paclitaxel and Carboplatin as Neoadjuvant Therapy

40 enrolled

Triple Negative Breast Neoplasms

NCT07539038 2026-04-20

Effects of Physical Activity in Early Stage Hormone Receptor Positive Breast Cancer Patients

44 enrolled

Breast Neoplasms

NCT04174742 2026-04-17

Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer

115 enrolled

Breast Neoplasms, Pain

NCT04889924 2026-04-17

ADARNAT

820 enrolled

Breast Neoplasms, Radiation Injuries

NCT05570253 2026-04-17

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

55 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05704062 2026-04-17

Quantitative MRI Assessment of Breast Cancer Therapy Response

135 enrolled

Breast Neoplasms

NCT06042569 2026-04-17

Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial

174 enrolled

Anatomic Stage I Breast Cancer AJCC v8

NCT06195709 2026-04-17

ECLECTIC

Phase 3 Recruiting

300 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT06427226 2026-04-17

Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity

46 enrolled

Breast Neoplasms

NCT06492759 2026-04-17

High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer

29 enrolled

Triple Negative Breast Neoplasms

NCT06823440 2026-04-17

CIPN

100 enrolled

Breast Neoplasms

NCT07253987 2026-04-17

SURV-QoL

200 enrolled

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT07285993 2026-04-17

Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET

15 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT07294703 2026-04-17

Factors Associated With Breast Cancer Risks and Outcomes

750 enrolled

Breast Neoplasms

NCT07400523 2026-04-17

Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy

Phase 3 Recruiting

446 enrolled

Breast Neoplasms

NCT02918474 2026-04-16

Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

15 enrolled

Carcinoma, Intraductal, Noninfiltrating

NCT05056818 2026-04-16

Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics

750 enrolled

Breast Neoplasms

NCT05534438 2026-04-16

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

46 enrolled

Breast Neoplasms

NCT05749588 2026-04-16

FUSCC Refractory TNBC Platform Study (FUTURE2.0)

120 enrolled

Triple Negative Breast Neoplasms

NCT06179303 2026-04-16

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

60 enrolled

Anatomic Stage III Breast Cancer AJCC v8

NCT06545682 2026-04-16

Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)

50 enrolled

BreastDermatologic

Breast Neoplasms, Melanoma

NCT06681064 2026-04-16

BELIEVE

500 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06964802 2026-04-16

The Effect of Cold Salt Water Foot Bath on the Development Of Chemotherapy-Induced Peripheral Neuropathy

30 enrolled

Breast Neoplasms

NCT07011654 2026-04-16

Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)

Phase 1/2 Recruiting

31 enrolled

Triple Negative Breast Neoplasms

NCT07447414 2026-04-16

LUBRECA

140 enrolled

Breast Neoplasms

NCT07467824 2026-04-16

PREACT

66 enrolled

Breast Neoplasms, Motor Activity

NCT00477100 2026-04-15

Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

1,200 enrolled

Neoplasms, Second Primary, Inflammatory Breast Neoplasms

NCT03604315 2026-04-15

Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF

300 enrolled

BreastGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04852887 2026-04-15

DEBRA

Phase 3 Recruiting

1,670 enrolled

Breast Neoplasms

NCT05042687 2026-04-15

Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer

300 enrolled

Breast Neoplasms

NCT05394259 2026-04-15

A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer